ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,347.40
0.45%
S&P ASX All Technology
3,799.90
0.91%
Brent Oil
79.54
-0.84%
US Dollar vs AUD
1.61093
-0.20%
Bitcoin
102,706.29
1.68%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Evoke Plc (EVOK) Share Price

Evoke Plc

Evoke Plc (EVOK)

Evoke Pharma Inc
72.50
3.80
(5.53%)
Closed 20 January 3:30AM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
72.50
Bid
72.95
Offer
73.65
Volume
5,766,317
72.30 Day's Range 76.65
49.20 52 Week Range 100.60
Market Cap
325.844M
Previous Close
68.70
Open
74.00
Last Trade
113
@
73.3
(O)
Last Trade Time
Financial Volume
4,277,552p
VWAP
74.1817
Average Volume (3m)
2,145,461
Shares Outstanding
449,440,402
Dividend Yield
-
PE Ratio
-680.48
Earnings Per Share (EPS)
-0.13
Revenue
1.71B
Net Profit
-56.4M

About Evoke Plc

Sector
Amusement & Rec Svcs, Nec
Industry
Amusement & Rec Svcs, Nec
Website
www.evokeplc.com
Headquarters
Gibraltar, Gbr
Founded
-
Evoke Plc is listed in the Amusement & Rec Svcs sector of the London Stock Exchange with ticker EVOK. The last closing price for Evoke was 68.70p. Over the last year, Evoke shares have traded in a share price range of 49.20p to 100.60p.

Evoke currently has 449,440,402 shares in issue. The market capitalisation of Evoke is £308.77 million. Evoke has a price to earnings ratio (PE ratio) of -680.48.

Ask ADVFN Intelligence (AI)

EVOK Latest News

More News

Evoke confident of further growth after lifting 2024 profit outlook

Evoke PLC on Friday raised annual guidance boosted by bookie-friendly sports results during the fourth quarter. The ...

17 January 2025
Alliance News

William Hill Limited evoke Announcement Containing Company Information

William Hill Limited 17 January 2025   NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART), DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD...

17 January 2025
RNS Regulatory News

Evoke PLC 2024 Post-close Trading Update

Evoke PLC 17 January 2025     17 January 2025   evoke Plc ("evoke" or "the Group")   2024 Post-close Trading Update   Double-digit revenue growth in Q4 driven by online; FY24 EBITDA expected...

17 January 2025
RNS Regulatory News

Evoke PLC Notice of Trading Update

Evoke PLC 13 January 2025                                                                                                      13 January 2025   evoke Plc ("evoke" or "the Group")   Notice of...

14 January 2025
RNS Regulatory News

Evoke PLC Holding(s) in Company

Evoke PLC 10 January 2025   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GI000A0F6407 Issuer Name EVOKE PLC UK or Non-UK Issuer UK 2. Reason for Notification...

11 January 2025
RNS Regulatory News

Evoke PLC Total Voting Rights

Evoke PLC 02 January 2025     2 January 2025 evoke plc ("evoke" or "the Company")   Total Voting Rights   In accordance with the FCA's Disclosure and Transparency Rules, evoke makes the...

02 January 2025
RNS Regulatory News

Evoke PLC Total Voting Rights

Evoke PLC 02 December 2024     2 December 2024 evoke plc ("evoke" or "the Company")   Total Voting Rights   In accordance with the FCA's Disclosure and Transparency Rules, evoke makes the...

02 December 2024
RNS Regulatory News

Evoke PLC Holding(s) in Company

Evoke PLC 11 November 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GI000A0F6407 Issuer Name EVOKE PLC UK or Non-UK Issuer UK 2. Reason for Notification...

11 November 2024
RNS Regulatory News

Evoke PLC Holding(s) in Company

Evoke PLC 01 November 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GI000A0F6407 Issuer Name 888 HOLDINGS PUBLIC LIMITED COMPANY UK or Non-UK Issuer UK...

01 November 2024
RNS Regulatory News

Evoke PLC Total Voting Rights

Evoke PLC 01 November 2024     1 November 2024 evoke plc ("evoke" or "the Company")   Total Voting Rights   In accordance with the FCA's Disclosure and Transparency Rules, evoke makes the...

01 November 2024
RNS Regulatory News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1101662.576.6556.75137207663.47129141DE
49.615.262321144762.976.6556.75220978963.13412516DE
1220.9540.640155189151.5576.6549.52214546159.73664937DE
26-13.35-15.550378567385.8586.6549.2198569260.0900525DE
52-4.65-6.0272197018877.15100.649.2172651470.39450422DE
156-192.7-72.6621417798265.2292.849.22081949101.71363567DE
260-81.2-52.8301886792153.749449.21682229148.71187039DE

EVOK - Frequently Asked Questions (FAQ)

What is the current Evoke share price?
The current share price of Evoke is 72.50p
How many Evoke shares are in issue?
Evoke has 449,440,402 shares in issue
What is the market cap of Evoke?
The market capitalisation of Evoke is GBP 308.77M
What is the 1 year trading range for Evoke share price?
Evoke has traded in the range of 49.20p to 100.60p during the past year
What is the PE ratio of Evoke?
The price to earnings ratio of Evoke is -680.48
What is the cash to sales ratio of Evoke?
The cash to sales ratio of Evoke is 22.43
What is the reporting currency for Evoke?
Evoke reports financial results in USD
What is the latest annual turnover for Evoke?
The latest annual turnover of Evoke is USD 1.71B
What is the latest annual profit for Evoke?
The latest annual profit of Evoke is USD -56.4M
What is the registered address of Evoke?
The registered address for Evoke is SUITE 601/701 EUROPORT, EUROPORT ROAD, GIBRALTAR, GIBRALTAR
What is the Evoke website address?
The website address for Evoke is www.evokeplc.com
Which industry sector does Evoke operate in?
Evoke operates in the AMUSEMENT & REC SVCS, NEC sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
QBTQuantum Blockchain Technologies Plc
1.625p
(124.14%)
460.21M
PPSProton Motor Power Systems Plc
0.425p
(112.50%)
3.73M
IMMImmupharma Plc
3.60p
(37.14%)
9.73M
MIRIMirriad Advertising Plc
0.20p
(25.00%)
51M
BMVBluebird Mining Ventures Ltd
0.75p
(25.00%)
30.39M
IGRIg Design Group Plc
59.00p
(-58.60%)
9.76M
CELCeladon Pharmaceuticals Plc
22.00p
(-31.25%)
1.23M
DGI9Digital 9 Infrastructure Plc
14.90p
(-25.87%)
14.49M
PREMPremier African Minerals Limited
0.0275p
(-23.61%)
2.06B
NOGNostrum Oil & Gas Plc
2.60p
(-20.12%)
30.22k
PREMPremier African Minerals Limited
0.0275p
(-23.61%)
2.06B
NTVONativo Resources Plc
0.0019p
(0.00%)
1.06B
TRPTower Resources Plc
0.031p
(-4.62%)
750.67M
SYMESupply@me Capital Plc
0.0039p
(16.42%)
550.3M
QBTQuantum Blockchain Technologies Plc
1.625p
(124.14%)
460.21M

Discussion

View Full Feed
HomerRomer HomerRomer 15 minutes ago
Any truth to "if you put in a sell order (no matter how high of a price), the shares will be protected from being lent to shorts"?
AVXL
Steady_T Steady_T 21 minutes ago
The compassionate use program would sure sound like RWE.
NWBO
S-BEES-BUMBLEBEE S-BEES-BUMBLEBEE 21 minutes ago
$TANH >>> She's ready for her big up-move, finally! ;-D

Nice Newsflow started!

Tantech Holdings Ltd. ($TANH) Subsidiary Gohomeway Group Inc. Successfully Registers EU Trademark
PR NEWSWIRE | 01/16/2025
https://www.prnewswire.com/news-releases/tantech-holdi
TANH
StockItOut StockItOut 22 minutes ago
https://www.saveboard.com.au
XERI
mrfence mrfence 24 minutes ago
ZERO $FMCC~ $FNMA~
FMCC FNMA
Lakota-45 Lakota-45 24 minutes ago
The 15% - Pre-Payment - has now been confirmed twice, and I'm assuming that
the S-1 has been filed. The S-1 has a 30 day approval, and if the SEC
doesn't respond in 30 days, . . . approval is automatic !!!

~ So Yes, . . it is very likely that both Companies will ann
INQD WDLF
SierraPacificRising SierraPacificRising 25 minutes ago
That's my boy ! Hookers and blow in Vegas my mofo. 
FNMA
BeachBum BeachBum 31 minutes ago
You said 75 mil coming off ask a few weeks ago. I know the 100 mil day volume wasn’t you.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175624344
PSRU
gitreal gitreal 33 minutes ago
Okay, you got me to go back and re-read the CMC PR. I still see only the info about the financial deal with NBRI for the mill. Nothing about the mill being fully permitted or in full operations, etc.

https://www.globenewswire.com/news-release/2025/01/15/3009809/0/en/CMC-Metals-Esta
CMC NBRI
StockItOut StockItOut 34 minutes ago
No end of story! Biza had a Xeriant Europe company before Duffy n Crew took Banjo & Matilda to change name to Xeriant, Inc., where then Xeriant, Inc. partnered with Xeriant Europe s.r.o. which had the name well prior.
XERI
mascale mascale 35 minutes ago
Comparing, only waterchaser poster knows the names of persons in outsourced former contactor offices(?).
HIRU
bwrbad bwrbad 38 minutes ago
bandwagon
RXRX
TightCoil TightCoil 40 minutes ago
Yes, We should sail,
Hoist The Main Sail
Hoist the Spinnaker
Catch Some Wind
FNMA
mascale mascale 43 minutes ago
The illiterate contrary posters fail to notice over $13.0 mil. cash in Q3 report and completion of successful Regulation S stock sales in 12/9 report--". . .we are proud to share that we have successfully secured partnerships with offshore investors through a Regulation S offering." Now Tasmanian mi
HIRU
TightCoil TightCoil 43 minutes ago
Reparations and Re-Listing on Big Board
Sing It Out - Shout It Out
Reparations and Re-Listing - Sing It
Reparations and Re-Listing - Shout It
FNMA
joeycav11 joeycav11 43 minutes ago
My take away from new regulations allowing MHRA use of real world evidence is that the data collected from treatments other types of cancer that used DC Vax via the compassionate care program can be used for submission of approvals for these new indications.
NWBO
Top Penny Top Penny 45 minutes ago
Probably picking up 20 million this coming week
PSRU
WiseYoda WiseYoda 46 minutes ago
Classic head fake….XRP will change direction once it finishes its course. Watch how it will change as were moving sideways now.
XRPUSD
jeunke22 jeunke22 47 minutes ago
Now that everybody received acknowledgment of their issues and frustrations with management , bonuses and perceived or real operational issues, can we go forward and concentrate at the huge opportunity in a civilized way?
The technology is real, the market is huge, new leadership is meant t
LWLG
Jack Torrance Jack Torrance 48 minutes ago
And I submit these documents through the "evidence" submittal part of the website?
ENZC
wadegarret wadegarret 48 minutes ago
COHR. CRMD, GERN, AESI, FEIM

A good 5 stocker. Two small caps. and three mid caps. GERN makes no money, but a bet on a drug that only has one competitor in the entire world to treat a deadly anemia. All 5 are good values imo
COHR CRMD GERN
TightCoil TightCoil 50 minutes ago
Your language/words are uncannily
similar to Rick Nagra. Say it isn't so.
FNMA
Truenorth2016 Truenorth2016 52 minutes ago
Looking forward to the next GCAN PR. Looking at other stocks with really good news and not running makes me believe there is no more teamwork left in the OTC. Been here on this board since 2015 and it feels like someone died coming to this platform. I mean most traders either changed their names or
GCAN

Your Recent History

LSE
EVOK
Evoke
TSX
NVDH.U
Harvest NVIDIA High Inco...
CSE
HEAT
Hillcrest Energy Technol...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads